Algorithm-based coagulation management of catastrophic amniotic fluid embolism

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 1, 2010, Pages 95-100

  Annecke, Thorsten ^a   Geisenberger, Thomas ^a   Kürzl, Rainer ^a   Penning, Randolph ^a   Heindl, Bernhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amniotic fluid; Anesthesia; Disseminated intravascular coagulation; Embolism; Tranexamic acid

Indexed keywords

ADRENALIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; HETASTARCH; LACTIC ACID; NORADRENALIN; PROTHROMBIN; RINGER LACTATE SOLUTION; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; VASOPRESSIN;

ADULT; ALGORITHM; AMNION FLUID EMBOLISM; APGAR SCORE; ARTERIAL GAS; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD GAS ANALYSIS; CARDIOTOCOGRAPHY; CASE REPORT; CAUSE OF DEATH; CLINICAL EVALUATION; CURETTAGE; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; GESTATIONAL AGE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTENSION; HYSTERECTOMY; INOTROPISM; INTENSIVE CARE UNIT; INTRACYTOPLASMIC SPERM INJECTION; LACTATE BLOOD LEVEL; LAPAROTOMY; LUNG EDEMA; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; OXYGEN THERAPY; OXYGENATION; PRIORITY JOURNAL; RESUSCITATION; SHOCK; SOMNOLENCE; TACHYCARDIA; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; UTERUS CONTRACTION; VACUUM EXTRACTION; VAGINA BLEEDING;

ACIDOSIS; ADULT; ALGORITHMS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; CARDIOVASCULAR AGENTS; CASE MANAGEMENT; CATASTROPHIC ILLNESS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EMBOLISM, AMNIOTIC FLUID; FATAL OUTCOME; FEMALE; FIBRINOGEN; HUMANS; HYPOTENSION; HYSTERECTOMY; INFANT, NEWBORN; MALE; MULTIPLE ORGAN FAILURE; PLACENTA, RETAINED; POSTPARTUM HEMORRHAGE; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC; THROMBELASTOGRAPHY; TRANEXAMIC ACID;

EID: 75649139932     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328332cfe2     Document Type: Article

References (17)

1. Henrich W, Surbek D, Kainer F, Grottke O, Hopp H, Kiesewetter H, et al. Diagnosis and treatment of peripartum bleeding. J Perinat Med 2008; 36:467-478.
2. Gist RS, Stafford IP, Leibowitz AB, Beilin Y. Amniotic fluid embolism. Anesth Analg 2009; 108:1599-1602.
3. Sinicina I, Pankratz H, Bise K, Matevossian E. Forensic aspects of postmortem histological detection of amniotic fluid embolism. Int J Legal Med 2009. doi 10.1007/s00414-009-0351-x. [Epub ahead of print]
4. Steiner PE, Lushbaugh C. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexplained death in obstetrics. JAMA 1941; 117:1245-1254.
5. Stolte L, van Kessel H, Seelen J, Eskes T, Wagatsuma T. Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol 1967; 98:694-697.
6. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172:1158-1167.
7. Ayoub CM, Zreik TG, Dabbous AS, Baraka AS. Amniotic fluid embolus: can we affect the outcome? Curr Opin Anaesthesiol 2003; 16:257-261.
8. Zhou J, Liu S, Ma M, Hou J, Yu H, Lu C, et al. Procoagulant activity and phosphatidylserine of amniotic fluid cells. Thromb Haemost 2009; 101:845-851.
9. Stafford I, Sheffield J. Amniotic fluid embolism. Obstet Gynecol Clin North Am 2007; 34:545-553.
10. Awad IT, Shorten GD. Amniotic fluid embolism and isolated coagulopathy: atypical presentation of amniotic fluid embolism. Eur J Anaesthesiol 2001; 18:410-413.
11. Lockwood CJ, Bach R, Guha A, Zhou X, Miller WA, Nemerson Y. Amniotic fluid contains tissue factor: a potent inhibitor of coagulation. Am J Obstet Gynecol 1991; 165:1335-1341.
12. Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005; 94:1213-1218.
13. Biron-Andreani C, Morau E, Schved JF, Hedon B, Dechaud H. Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 2003; 33:170-171.
14. Stroup J, Haraway D, Beal JM. Aprotinin in the management of coagulopathy associated with amniotic fluid embolism. Pharmacotherapy 2006; 26:689-693.
15. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266-273.
16. Orlikowski CEP, Rocke DA, Murray WB, Gous E, Moadley J, Kenoyer DG, et al. Thrombelastography changes in preeclampsia and eclampsia. Br J Anaesth 1996; 77:157-161.
17. Kahyaoglu I, Kahyaoglu S, Mollamahmutoglu L. Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise. Arch Gynecol Obstet 2009; 280:127-129.